Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial
Table 2
Angiographic and procedural features of the two groups.
Variable
Danlou Tablet group ()
Placebo group ()
()
value
Multivessel coronary artery disease, number (%)
62 (56.9)
63 (57.3)
0.00
0.95
Vessel treated, number (%)
Left main
2 (1.8)
2 (1.8)
1.0
Left anterior descending
73 (67.0)
65 (59.1)
1.46
0.23
Left circumflex
26 (23.9)
34 (30.9)
1.37
0.24
Right coronary artery
35 (32.1)
30 (27.3)
0.61
0.43
Restenotic lesions, number (%)
1 (0.9)
1 (0.9)
1.00
Multivessel intervention, number (%)
24 (22.0)
18 (16.4)
1.13
0.29
Type of intervention, number (%)
Balloon only
1 (0.9)
1 (0.9)
1.0
Stent
108 (99.1)
109 (99.1)
1.0
Number of stents per patient
0.37
Stent diameter, mm
0.39
Total stent length, mm
0.02
Values are given as number of patients (%) or mean ± SD. value is from Fisher’s exact test.
